Breast epithelial cell proliferation is markedly increased with short-term high levels of endogenous estrogen secondary to controlled ovarian hyperstimulation

Breast Cancer Research and Treatment

Volumn 132, Issue 2, 2012, Pages 653-660

  Chung, Karine ^a   Hovanessian Larsen, Linda J ^a   Hawes, Debra ^a   Taylor, DeShawn ^a   Downey, Susan ^a   Spicer, Darcy V ^a   Stanczyk, Frank Z ^a   Patel, Sherfaraz ^a   Anderson, A Rebecca ^a   Pike, Malcolm C ^a,b   Wu, Anna H ^a   Pearce, Celeste Leigh ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Breast epithelium; Estradiol; Oocyte donors; Pregnancy

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR ALPHA; KI 67 ANTIGEN; PROGESTERONE RECEPTOR A; PROGESTERONE RECEPTOR B;

ARTICLE; BREAST DUCT; BREAST EPITHELIUM; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATION PERIOD; GESTATIONAL AGE; HUMAN; HUMAN CELL; HUMAN TISSUE; MENSTRUAL CYCLE; OOCYTE DONATION; OVARY HYPERSTIMULATION; PREGNANT WOMAN; PRIORITY JOURNAL;

BIOPSY; CELL PROLIFERATION; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FEMALE; FERTILITY AGENTS, FEMALE; GESTATIONAL AGE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; LOS ANGELES; MAMMARY GLANDS, HUMAN; OOCYTE DONATION; OVULATION INDUCTION; PREGNANCY; PROGESTERONE; PROSPECTIVE STUDIES; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES; TIME FACTORS; UP-REGULATION;

EID: 84859100312     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1870-y     Document Type: Article

References (39)

1. Bernstein L, Ross RK (1993) Endogenous hormones and breast cancer risk. Epidemiol Rev 15:48-65 (Pubitemid 23269070)
2. Pike MC, Wu AH, Spicer DV, Lee S, Pearce CL (2007) Estrogens, progestins, and risk of breast cancer. Ernst Scher Found Symp Proc 1:127-150
3. Papageorgiou T, Guibert J, Goffinet F, Patrat C, Fulla Y, Janssens Y, Zorn JR (2002) Percentile curves of serum estradiol levels during controlled ovarian stimulation in 905 cycles stimulated with recombinant FSH show that high estradiol is not detrimental to IVF outcome. Hum Reprod 17:2846-2850. doi:10.1093/ humrep/17.11.2846
4. Peña JE, Chang PL, Chan LK, Zeitoun K, Thornton MH 2nd, Sauer MV (2002) Supraphysiological estradiol levels donot affect oocyte and embryo quality in oocyte donation cycles. Hum Reprod 17:83-87. doi:10.1093/humrep/17.1. 83 (Pubitemid 34130265)
5. Taylor D, Pearce CL, Hovanessian-Larsen L, Downey S, Spicer DV, Bartow S, Pike MC, Wu AH, Hawes D (2009) Progesterone and estrogen receptors in pregnant and pre-menopausal nonpregnant normal human breast. Breast Cancer Res Treat 118:161-168. doi:10.1007/s10549-009-0322-4
6. Probst-Hensch NM, Ingles SA, Diep AT, Haile RW, Stanczyk FZ, Kolonel LN, Henderson BE (1999) Aromatase and breast cancer susceptibility. Endocr Relat Cancer 6:165-173. doi:10.1677/erc.0.0060165 (Pubitemid 29260048)
7. Scott JZ, Stanczyk FZ, Goebelsmann U, Mishell DR (1978) A double-antibody radioimmunoassay for serum progesterone using progesterone-3-(0-carboxymethyl) oximino-[125I]-iodo-histamine as radioligand. Steroids 31:393-405 (Pubitemid 9126236)
8. Södergård R, Bäckström T, Shanbhag V, Carstensen H (1982) Calculation of free and bound fractions of testosterone and estradiol- 17 beta to human plasma proteins at body temperature. J Steroid Biochem 16:801-810. doi:10.1016/0022-4731(82)90038-3 (Pubitemid 13228095)
9. Dunn JF, Nisula BC, Rodbard D (1981) Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone- binding globulin and corticosteroid-binding globulin in human plasma. J Clin Endocrin Metab 53:58-68. doi:10.1210/ jcem-53-1-58
10. Goebelsmann U, Mishell DR (1979) The menstrual cycle. In: Mishell DR, Davajan V (eds) Reproductive endocrinology, infertility and contraception. FA Davis, Philadelphia, pp 67-89
11. Lobo RA (1997) Endocrinology of pregnancy. In: Lobo RA, Mishell DR, Paulson RJ, Shoupe D (eds) Mishell's textbook of infertility, contraception, and reproductive endocrinology, 4th edn. Blackwell Science, Malden, pp 183-206
12. Levitz M, Young BK (1977) Estrogens in pregnancy. Vitam Horm 35:109-147
13. Goebelsmann U (1979) Protein and steroid hormones in pregnancy. J Reprod Med 23:166-177
14. Barberia JM, Abu-Fadl S, Kletzky OA, Nakamura RM, Mishell DR (1975) Serum prolactin patterns in early gestation. Am J Obstet Gynecol 121:1107-1110
15. Das R, Vonderhaar BK (1997) Prolactin as amitogen in mammary cells. J Mammary Gland Biol Neoplasia 2:29-39
16. Gutzman JH, Miller KK, Schuler LA (2004) Endogenous human prolactin and not exogenous human prolactin induces estrogen receptor alpha and prolactin receptor expression and increases estrogen responsiveness in breast cancer cells. J Steroid Biochem Mol Biol 88:69-77. doi:10.1016/j.jsbmb.2003.10.008 (Pubitemid 38326599)
17. Trichopoulos D, Hsieh CC, MacMahon B, Lin TM, Lowe CR, Mirra AP, Ravnihar B, Salber EJ, Valaoras VG, Yuasa S (1983) Age atany birth and breast cancer risk. Int J Cancer 31:701-704. doi:10.1002/ijc.2910310604 (Pubitemid 13060771)
18. Pike MC, Krailo MD, Henderson BE, Casagrande JT, Hoel DG (1983) 'Hormonal' risk factors, 'breast tissue age' and the age-incidence of breast cancer. Nature 303:767-770. doi:10.1038/303767a0 (Pubitemid 13054488)
19. Wohlfahrt J, Melbye M (2001) Age atany birth is associated with breast cancer risk. Epidemiology 12:68-73 (Pubitemid 32006464)
20. Albrektsen G, Heuch I, Hansen S, Kvale G (2005) Breast cancer risk by age at birth, time since birth and time intervals between births: exploring interaction effects. Br J Cancer 92:167-175. doi:10.1038/sj.bjc.6602302 (Pubitemid 40188451)
21. Schedin P (2006) Pregnancy-associated breast cancer and metastasis. Nat Rev Cancer 9:281-291. doi:10.1038/nrc1839
22. Ginger MR, Gonzalez-Rimbua MF, Gay JP, Rosen JM (2001) Persistent changes in gene expression induced by estrogen and progesterone in the rat mammary gland. Mol Endocrinol 15:1993-2009. doi:10.1210/me.15.11.1993 (Pubitemid 33022536)
23. Blakely CM, Stoddard AJ, Belka GK, Dugan KD, Notarfrancesco KL, Moody SE, D'Cruz CM, Chodosh LA (2006) Hormoneinduced protection against mammary tumorigenesis is conserved in multiple rat strains and identifies a core gene expression signature induced by pregnancy. Cancer Res 66:6421-6431; erratum in 2007; 67:844-846. doi:10.1158/0008-5472.CAN-05-4235
24. Collaborative Group on Hormonal Factors in Breast Cancer (2004) Breast cancer and abortion: collaborative reanalysis of data from 53 epidemiological studies, including 83,000 with breast cancer from 16 countries. Lancet 363:1007-1016. doi:10.1016/S0140-6736(04)15835-2
25. Medina D (2004) Breast cancer: the protective effect of pregnancy. Clin Cancer Res 10:380S-384S
26. Sinha DK, Pazik JE, Dao TL (1988) Prevention of mammary carcinogenesis in rats by pregnancy: effect of full-term and interrupted pregnancy. Br J Cancer 57:390-394
27. Russo J, Russo IH (1980) Susceptibility of the mammary gland to carcinogenesis: II. Pregnancy interruption as a risk factor in tumor incidence. Am J Pathol 100:497-512 (Pubitemid 10037090)
28. Grubbs CJ, Farnell DR, Hill DL, McDonough KC (1985) Chemoprevention of N-nitroso-N-methylurea-induced mammary cancers by pretreatment with 17β-estradiol and progesterone. J Natl Cancer Inst 74:927-931 (Pubitemid 15118254)
29. Guzman RC, Yang J, Rajkumar L, Thordarson G, Chen X, Nandi S (1999) Hormonal prevention of breast cancer: mimicking the protective effect of pregnancy. Proc Natl Acad Sci USA 96:2520-2525. doi:10.1073/pnas.96.5.2520 (Pubitemid 29117948)
30. Medina D, Peterson LE, Moraes R, Gay J (2001) Short-term exposure to estrogen and progesterone induces partial protection against N-nitroso-N-methylurea-induced mammary tumorigenesis in Wistar-Furth rats. Cancer Lett 169:1-6. doi:10.1016/S0304- 3835(01)00507-9
31. O'Leary P, Boyne P, Flett P, Beilby J, James I (1991) Longitudinal assessment of changes in reproductive hormones during normal pregnancy. Clin Chem 37:667-672 (Pubitemid 21892706)
32. Numan M (1994) Maternal behavior. In: Knobil E, Neill JD (eds) The physiology of reproduction. Raven Press, New York, pp 221-302
33. Kalra PS, Kalra SP (1977) Temporal changes in the hypothalamic and serum luteinizing hormone-releasing hormone (LH-RH) levels and the circulating ovarian steroids during the rat oestrous cycle. Acta Endocrinol 85:449-455 (Pubitemid 8131601)
34. Nequin LG, Alvarez J, Schwartz NB (1979) Measurement of serum steroid and gonadotropin levels and uterine and ovarianvariables throughout the 4 day and 5 day estrous cycles in the rat. Biol Reprod 20:659-670 (Pubitemid 9156442)
35. Haim S (2003) Serum levels of sex hormones and corticosterone throughout 4- and 5-day estrous cycles in Fischer 344 rats and their simulation in ovariectomized females. J Endocrinol Invest 26:1013-1022
36. Strange R, Westerlind KC, Ziemiecki A, Andres A-C (2007) Proliferation and apoptosis in mammary epithelium during the rat oestrus cycle. Acta Physiol 190:137-149. doi:10.1111/j.1748- 1716.2007.01704.x
37. Guzman RC, Rajkumar L, Thordarson G, Nandi S (2005) Pregnancy levels of estrogen prevents mammary cancers. In: Li JJ, Li SA, Llombart-Bosch A (eds) Hormonal carcinogenesis IV. Springer, New York, pp 427-430
38. Sanyal MK (1978) Secretion of progesterone during gestation in the rat. J Endocrinol 79:179-190. doi:10.1677/joe.0.0790179
39. Macdonald GJ, Matt DW (1984) Adrenal and placental steroid secretion during pregnancy in the rat. Endocrinology 114:2068-2073. doi:10.1210/endo-114- 6-2068